4.5 Article

miR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor α

Journal

MOLECULAR MEDICINE REPORTS
Volume 12, Issue 5, Pages 7072-7078

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2015.4263

Keywords

miR-34a; colon cancer; platelet-derived growth factor receptor alpha

Funding

  1. Joint Funds of the Natural Science Foundation of Liaoning Province [2013023024]
  2. National Natural Science Foundation of China [81172052]
  3. Yingcai Program of Dalian Medical University

Ask authors/readers for more resources

The microRNA (miRNA), miR-34a is significant in colon cancer progression. In the present study, the role of miR-34a in colon cancer cell proliferation and metastasis was investigated. It was found that the expression of miR-34a in colon cancer tissues and cell lines was lower when compared with that of normal tissues and cells. Further research demonstrated that miR-34a inhibited cell proliferation, induced G(1) phase arrest, and suppressed metastasis and epithelial mesenchymal transition in colon cancer cells. Bioinformatic prediction indicated that platelet-derived growth factor receptor a (PDGFRA) was a potential target gene of miR-34a and a luciferase assay identified that PDGFRA was a novel direct target gene of miR-34a. In addition, assays of western blot analyses and quantitative reverse-transcription polymerase chain reaction confirmed that miR-34a decreased PDGFRA mRNA expression and protein levels in colon cancer cells. Assessment of cellular function indicated that miR-34a inhibited colon cancer progression via PDGFRA. These findings demonstrate that miR-34a may act as a negative regulator in colon cancer by targeting PDGFRA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available